SLINDA

This brand name is authorized in Ecuador, Spain, Finland, France, Poland

Active ingredients

The drug SLINDA contains one active pharmaceutical ingredient (API):

1 Drospirenone UNII N295J34A25 - DROSPIRENONE

Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone. Read about Drospirenone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AC10		G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5915-MEE-0221
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 84603
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 061682, 442936
Country: FR	Base de données publique des médicaments	Identifier(s): 68971188
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100410232